ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,08
1,24%
Dow Jones
39 308,00
-0,06%
DAX
18 374,53
1,22%
Brent Oil
86,725
-0,21%
Bitcoin
58 914,60
-2,07%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. CSE
  6. Lexaria Bioscience Corp (LXX)

  7. Lexaria Bioscience Corp (LXX) Actualités

LXX

Lexaria Bioscience (LXX)

Lexaria Bioscience Corp
De:
Trier par:
 Showing the most relevant articles for your search:CSE:LXX
DateHeureSourceTitreSymboleSociété
20/05/202113h16InvestorsHub NewsWireLexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..contCSE:LXXLexaria Bioscience Corp
22/04/202113h30InvestorsHub NewsWireLexaria Commences Human Clinical Hypertension StudyCSE:LXXLexaria Bioscience Corp
14/04/202113h37InvestorsHub NewsWireLexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope NetworkCSE:LXXLexaria Bioscience Corp
06/04/202113h16InvestorsHub NewsWireLexaria to Evaluate DehydraTECHTM in Multiple New MarketsCSE:LXXLexaria Bioscience Corp
24/03/202113h00InvestorsHub NewsWireLexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD BeveragesCSE:LXXLexaria Bioscience Corp
10/03/202117h54InvestorsHub NewsWireCould DehydraTECH(TM) CBD be Worth $3 Billion a Year to Lexaria?CSE:LXXLexaria Bioscience Corp
27/01/202114h00InvestorsHub NewsWireCANNABIS INVESTING - Khiron (KHRNF) & Lexaria (LEXX) with Ted OhashiCSE:LXXLexaria Bioscience Corp
16/12/202016h00InvestorsHub NewsWireCANNABIS INVESTING - Cannabis News, Khiron, & Lexaria BioscienceCSE:LXXLexaria Bioscience Corp
01/12/202012h41InvestorsHub NewsWireLexaria's Patented Technology Significantly Enhances Oral Delivery of Antiviral DrugsCSE:LXXLexaria Bioscience Corp
04/09/201914h45InvestorWireInnovative Drug-Delivery Systems Benefit Patients and BusinessesCSE:LXXLexaria Bioscience Corp
11/06/201914h45InvestorWireDramatically Improved Delivery Systems Promise More Effective Cannabis TreatmentsCSE:LXXLexaria Bioscience Corp
29/05/201914h45InvestorWireDisruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, EdiblesCSE:LXXLexaria Bioscience Corp
30/01/201914h45InvestorWireOutside Investment, New Technology Support Growing Cannabis IndustryCSE:LXXLexaria Bioscience Corp
16/01/201914h45InvestorWireDefinitive Agreement Marks Milestone for Alternative Nicotine Delivery OptionsCSE:LXXLexaria Bioscience Corp
28/11/201814h45InvestorWireBooming Cannabis Consumables Space Continues to see Product InnovationsCSE:LXXLexaria Bioscience Corp
22/10/201814h45InvestorWireCanada Leads International Cannabis Boom — and It’s Not About SmokingCSE:LXXLexaria Bioscience Corp
04/10/201814h45InvestorWireIntangible Assets Power Growth, Acquisitions in the Pharmaceuticals SectorCSE:LXXLexaria Bioscience Corp
15/08/201814h45InvestorWireBig Businesses Look for Healthier Alternatives to Smoking for Drug DeliveryCSE:LXXLexaria Bioscience Corp
24/04/201814h45InvestorWireInnovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech SectorsCSE:LXXLexaria Bioscience Corp
03/04/201814h45InvestorWireCannabis Biotech BoomsCSE:LXXLexaria Bioscience Corp
06/02/201814h45InvestorWireCannabis Deals Cross the Billion-Dollar Mark in CanadaCSE:LXXLexaria Bioscience Corp
09/01/201814h45InvestorWireIntriguing Research into Pathways to Limit Nicotine, Quit Cigarette UseCSE:LXXLexaria Bioscience Corp
09/11/201716h12InvestorsHub NewsWireLexaria Bioscience Files Innovative New Patent ApplicationCSE:LXXLexaria Bioscience Corp
02/11/201713h45InvestorWireBioabsorption Breakthrough Shows Promise for Tobacco, Cannabinoids, MedicationCSE:LXXLexaria Bioscience Corp
01/11/201714h32InvestorsHub NewsWireLexaria Bioscience Receives Groundbreaking U.S. Patent Allowance for its DehydraTECHTM Delivery of THC, NSAIDs, and Nicotine ...CSE:LXXLexaria Bioscience Corp
19/09/201714h45InvestorWireAdvances in Drug Delivery Hold the Promise of Reducing Inevitable Side EffectsCSE:LXXLexaria Bioscience Corp
06/09/201714h45InvestorWireLandmark M&A Deals Continue to Shape Big PharmaCSE:LXXLexaria Bioscience Corp
16/08/201714h45InvestorWireFDA Proposal Puts Spotlight on Big Tobacco and Industry InnovatorsCSE:LXXLexaria Bioscience Corp
27/07/201714h45InvestorWireBiotech Players Lead the Growth Charge in the Legal Cannabis MarketCSE:LXXLexaria Bioscience Corp
19/01/201715h11InvestorsHub NewsWireLEXARIA AND NEUTRISCI ANNOUNCE SUCCESSFUL CANNABINOID TABLET DEVELOPMENT AND POSITIVE RESULTSCSE:LXXLexaria Bioscience Corp
 Showing the most relevant articles for your search:CSE:LXX

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
BN
Danone
EU
AF
Air FranceKLM
EU
EN
Bouygues
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
USI
USTECH100
US Tech 100
EU
SGO
Cie de SaintGobain
NYSE
MCD
McDonalds
EU
CS
Axa
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
EU
ORA
Orange
EU
HO
Thales
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés